These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2090935)

  • 1. Antifungal combination therapy in localized candidosis.
    Polak A
    Mycoses; 1990; 33(7-8):353-8. PubMed ID: 2090935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A
    Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new experimental model of localized candidosis for the study of antifungal chemotherapy.
    Polak A; Schaffner A
    Mycoses; 1989 Aug; 32(8):398-404. PubMed ID: 2797055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
    Polak A; Scholer HJ; Wall M
    Chemotherapy; 1982; 28(6):461-79. PubMed ID: 6297858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
    Rabinovich S; Shaw BD; Bryant T; Donta ST
    J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179
    [No Abstract]   [Full Text] [Related]  

  • 6. Flucytosine.
    Bennet JE
    Ann Intern Med; 1977 Mar; 86(3):319-21. PubMed ID: 320931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo studies on synergistic antifungal activity.
    Shadomy S
    Contrib Microbiol Immunol; 1977; 4():147-57. PubMed ID: 342191
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination of antifungal chemotherapeutic agents in experimental candidiasis in mice].
    Bassetti D; Fabbri A; Navone C; Ciravegna B
    Ann Sclavo; 1977; 19(5):1043-8. PubMed ID: 616259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice.
    Titsworth E; Grunberg E
    Antimicrob Agents Chemother; 1973 Sep; 4(3):306-8. PubMed ID: 4586144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination antifungal therapy: where are we now, and where are we going?
    Marr K
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):24-9. PubMed ID: 15651179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A
    Chemotherapy; 1978; 24(1):2-16. PubMed ID: 338264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of antifungal agents in combination with fleroxacin, a new quinolone.
    Polak A
    Mycoses; 1990 Apr; 33(4):173-8. PubMed ID: 2122247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined antifungal therapy in a murine infection by Candida glabrata.
    Mariné M; Serena C; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Candida meningitis with amphotericin B and 5-fluorocytosine in combination.
    Chesney PJ; Teets KC; Mulvihill JJ; Salit IE; Marks MI
    J Pediatr; 1976 Dec; 89(6):1017-9. PubMed ID: 993903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida glabrata infection after total hip arthroplasty.
    Ramamohan N; Zeineh N; Grigoris P; Butcher I
    J Infect; 2001 Jan; 42(1):74-6. PubMed ID: 11243760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses.
    Kujath P; Lerch K; Kochendörfer P; Boos C
    Infection; 1993; 21(6):376-82. PubMed ID: 8132367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the effect of combination of amphotericin B and flucytosine on Candida albicans by flow cytometry].
    Taguchi H; Tanaka R; Miyaji M; Nishimura K; Kanno H; Ishiyama H
    Kansenshogaku Zasshi; 1992 Apr; 66(4):516-21. PubMed ID: 1624846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on invasive candidiasis.
    Rodriguez LJ; Rex JH; Anaissie EJ
    Adv Pharmacol; 1997; 37():349-400. PubMed ID: 8891107
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.